Last Updated:
Searching
Create account to add to watchlist!

Advanced Merger Partners, Inc. - AMPI

  • Commons

    $9.76

    -0.20%

    AMPI Vol: 19.0

  • Warrants

    $0.91

    +10.18%

    AMPI+ Vol: 100.0

  • Units

    $9.86

    -0.20%

    AMPI= Vol: 1.3K

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 280.6M
Average Volume: 27.7K
52W Range: $9.60 - $10.07
Weekly %: -0.20%
Monthly %: +0.10%
Inst Owners: 46

Info

Target: Searching
Days Since IPO: 278
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-fourth of one redeemable warrant
Trust Size: 25000000.0M

Management

Officers, Directors and Director Nominees.” Members of our management team and our Investment Committee presently have, and any of them in the future may have additional, certain duties and/or fiduciary or contractual obligations to other entities and other personal and financial interests and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. Following the completion of this offering and until we consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses. From time to time, each of our Houlihan-affiliated officers and directors may, by virtue of their employment at Houlihan, have certain duties, or be subject to contractual obligations, to Houlihan clients, while the Saddle Point-affiliated and other of our officers and directors presently have (and any of them in the future may have additional) fiduciary or contractual obligations to clients and other entities (or clients of such entities). These duties and/or contractual and fiduciary obligations (as applicable) may, in certain cases, require an officer or director to present a business combination opportunity or other opportunity to such client or entity (or clients of such entity) instead of us, and, in such cases, he or she will honor these duties or obligations. In addition, our sponsor, members of our management team and our Investment Committee, and their respective affiliates may pursue other business or investment ventures during the period in which we are seeking an initial business combination. As a result, our sponsor, members of our management team and our Investment Committee could have conflicts of interest in determining whether to present business combination opportunities to us or to any other company with which they are or may become involved. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. Although we have no formal policy in place for vetting potential conflicts of interest, our board of directors will review potential conflicts of interest on a case-by-case basis. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer or their affiliates unless such opportunity is expressly offered to such person solely in his or her capacity as our director or officer and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. 82 Table of Contents For a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Management—Officers, Directors and Director Nominees,” “Management—Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” Since our sponsor, executive officers, and directors will lose their entire investment in us if our initial business combination is not completed (other than with respect to public shares they may acquire during or after this offering), a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. In December 2020 and January 2021, our sponsor and our independent director nominees purchased an aggregate of 7,187,500 founder shares in exchange for a capital contribution of $25,000, or approximately $0.003 per share. Prior to the initial investment in the company of $25,000 by our sponsor and our independent director nominees, the company had no assets, tangible or intangible. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 28,750,000 units if the underwriters’ over-allotment option is exercised in full, and therefore that such founder shares would represent 20% of the outstanding shares after this offering. Up to 937,500 of the founder shares will be forfeited depending on the extent to which the underwriters’ over-allotment is exercised. The founder shares will be worthless if we do not complete an initial business combination. In addition, our sponsor has committed to purchase an aggregate of 5,166,667 private placement warrants (or 5,666,667 warrants if the underwriters’ over-allotment option is exercised in full), each exercisable for one share of Class A common stock at $11.50 per share, for an aggregate purchase price of $7,750,000 (or $8,500,000 if the underwriters’ over-allotment option is exercised in full), or $1.50 per warrant, that will also be worthless if we do not complete our initial business combination. The personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business combination and influencing the operation of the business following the initial business combination. This risk may become more acute as the 24-month anniversary of the closing of this offering nears, which is the deadline for our completion of an initial business combination. Members of our management team and our Investment Committee, our sponsor, and their respective affiliates may have competitive pecuniary interests that conflict with our interests. We have not adopted a policy that expressly prohibits members of our management team or our Investment Committee, our sponsor, or their respective affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination with a target business that is affiliated with our sponsor or members of our management team or our Investment Committee, although we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours. The personal and financial interests of the members of our management team and our Investment Committee, our sponsor, and their respective affiliates may influence their motivation in timely identifying and selecting a target business and completing a business combination. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable target business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our stockholders’ best interest. If this were the case, it may be a breach of their fiduciary duties to us as a matter of Delaware law and we or our stockholders might have a claim against such individuals for infringing on our stockholders’ rights. However, we might not ultimately be successful in any claim we may make against them for such reason. 83 Table of Contents We may engage in a business combination with one or more target businesses that may be affiliated with, or that have other relationships with, our sponsor, members of our management team or our Investment Committee, our existing holders, or their respective affiliates, which may raise potential conflicts of interest. In light of the involvement of our sponsor, members of our management team and our Investment Committee, or existing holders, and their respective affiliates with other entities, we may decide to acquire one or more businesses affiliated with, or that have other relationships with, our sponsor, members of our management team or our Investment Committee, or existing holders, or their respective affiliates. Members of our management team and our Investment Committee also serve as officers and board members for other entities, including, without limitation, those described under “Management — Conflicts of Interest.” Such entities may compete with us for business combination opportunities. Our sponsor and members of our management team and our Investment Committee are not currently aware of any specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there have been no substantive discussions concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction with any entities affiliated our sponsor, members of our management team or our Investment Committee, or existing holders, we would pursue such a transaction if we determined that such affiliated entity met our criteria for a business combination as set forth in “Proposed Business — Effecting our initial business combination — Selection of a target business and structuring of our initial business combination” and such transaction was approved by a majority of our independent and disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm which is a member of FINRA or an independent accounting firm regarding the fairness to our company from a financial point of view of a business combination with one or more domestic or international businesses affiliated with our sponsor, executive officers, directors or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public stockholders as they would be absent any conflicts of interest. We may not have sufficient funds to satisfy indemnification claims of our directors and executive officers. We have agreed to indemnify our officers and directors to the fullest extent permitted by law. However, our officers and directors have agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account and to not seek recourse against the trust account for any reason whatsoever. Accordingly, any indemnification provided will be able to be satisfied by us only if (i) we have sufficient funds outside of the trust account or (ii) we consummate an initial business combination. Our obligation to indemnify our officers and directors may discourage stockholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful, might otherwise benefit us and our stockholders. Furthermore, a stockholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions. Risks Relating to the Trust Account The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the per-share redemption amount received by public stockholders may be less than $10.00 per share. The proceeds held in the trust account will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive 84 Table of Contents rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we are unable to complete our initial business combination or make certain amendments to our amended and restated certificate of incorporation, our public stockholders are entitled to receive their pro-rata share of the proceeds held in the trust account, plus any interest income, net of taxes payable (less, in the case we are unable to complete our initial business combination, up to $100,000 of interest to pay dissolution expenses). Negative interest rates could reduce the value of the assets held in trust such that the per-share redemption amount received by public stockholders may be less than $10.00 per share. You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. Our public stockholders will be entitled to receive funds from the trust account only upon the earlier to occur of: (i) our completion of an initial business combination, and then only in connection with those shares of Class A common stock that such stockholder properly elected to redeem, subject to the limitations described herein, (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend our amended and restated certificate of incorporation to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity, and (iii) the redemption of our public shares if we are unable to complete an initial business combination within 24 months from the closing of this offering, subject to applicable law and as further described herein. In addition, if our plan to redeem our public shares if we are unable to complete an initial business combination within 24 months from the closing of this offering is not completed for any reason, compliance with Delaware law may require that we submit a plan of dissolution to our then-existing stockholders for approval prior to the distribution of the proceeds held in our trust account. In that case, public stockholders may be forced to wait beyond 24 months from the closing of this offering before they receive funds from our trust account. In no other circumstances will a public stockholder have any right or interest of any kind in the trust account. Holders of warrants will not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a loss. If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by stockholders may be less than $10.00 per share. Our placing of funds in the trust account may not protect those funds from third party claims against us. Although we will seek to have all vendors, service providers (except for our independent registered public accountant), prospective target businesses and other entities with which we do business execute agreements with us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public stockholders, such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that has not executed a waiver if management believes that such third party’s engagement would be significantly more beneficial to us than any alternative. The 85 Table of Contents underwriters of this offering will not execute agreements with us waiving such claims to the monies held in the trust account. Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we are unable to complete our initial business combination within the prescribed timeframe, or upon the exercise of a redemption right in connection with our initial business combination, we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the 10 years following redemption. Accordingly, the per-share redemption amount received by public stockholders could be less than the $10.00 per public share initially held in the trust account, due to claims of such creditors. Pursuant to the letter agreement the form of which is filed as an exhibit to the registration statement of which this prospectus forms a part, our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per public share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, we have not asked our sponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and we believe that our sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. As a result, if any such claims were successfully made against the trust account, the funds available for our initial business combination and redemptions could be reduced to less than $10.00 per public share. In such event, we may not be able to complete our initial business combination, and you would receive such

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 39.64%
% of Float Held by Institutions 39.64%
Number of Institutions Holding Shares 46

Mutual Fund Holders

Holder Shares Date Reported Value % Out
AQR Funds-AQR Diversified Arbitrage Fd 82398 2021-06-29 802556 0.29

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Schonfeld Strategic Advisors LLC 25,000 $240,000 0.0% 0 0.070%
2021-11-16 Citadel Advisors LLC 175,209 $1,700,000 0.0% -2.3% 0.488%
2021-11-15 HBK Investments L P 250,002 $2,430,000 0.0% -5.6% 0.696%
2021-11-15 Linden Advisors LP 400,000 $3,880,000 0.0% -14.3% 1.113%
2021-11-12 PEAK6 Investments LLC 50,292 $490,000 0.0% -13.8% 0.140%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q FORM 10-Q 2021-11-12 https://www.sec.gov/Archives/edgar/data/1835636/000119312521328133/d619362d10q.htm
10-Q 10-Q 2021-08-13 https://www.sec.gov/Archives/edgar/data/1835636/000119312521246245/d179390d10q.htm
SC 13G/A 2021-07-29 https://www.sec.gov/Archives/edgar/data/1835636/000079684821000011/Advanced_Merger_13G-A.htm
10-Q 10-Q 2021-05-17 https://www.sec.gov/Archives/edgar/data/1835636/000119312521163894/d136150d10q.htm
SC 13G 2021-05-04 https://www.sec.gov/Archives/edgar/data/1835636/000079684821000007/Advanced_Merger_13G_2021.htm
8-K 8-K 2021-03-10 https://www.sec.gov/Archives/edgar/data/1835636/000119312521076366/d93037d8k.htm
4 FORM 4 SUBMISSION 2021-03-08 https://www.sec.gov/Archives/edgar/data/1835636/000089924321010420/xslF345X03/doc4.xml
8-K 8-K 2021-03-05 https://www.sec.gov/Archives/edgar/data/1835636/000119312521071457/d138573d8k.htm
424B4 424B4 2021-03-03 https://www.sec.gov/Archives/edgar/data/1835636/000119312521067869/d12924d424b4.htm
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008841/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008840/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008839/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008838/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008837/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008836/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008835/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-02 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008834/xslF345X02/doc3.xml
EFFECT 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835636/999999999521000775/xslEFFECTX01/primary_doc.xml
3 FORM 3 SUBMISSION 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008818/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835636/000089924321008817/xslF345X02/doc3.xml
CERT NYSE CERTIFICATION 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835636/000087666121000268/AMPI030121.pdf
8-A12B 8-A12B 2021-03-01 https://www.sec.gov/Archives/edgar/data/1835636/000119312521062953/d317260d8a12b.htm
CORRESP 2021-02-25 https://www.sec.gov/Archives/edgar/data/1835636/000119312521057259/filename1.htm
CORRESP 2021-02-25 https://www.sec.gov/Archives/edgar/data/1835636/000119312521057232/filename1.htm
S-1/A S-1/A 2021-02-25 https://www.sec.gov/Archives/edgar/data/1835636/000119312521055064/d12924ds1a.htm
CORRESP 2021-02-24 https://www.sec.gov/Archives/edgar/data/1835636/000119312521055075/filename1.htm
UPLOAD 2021-02-24 https://www.sec.gov/Archives/edgar/data/1835636/000000000021002244/filename1.pdf
S-1/A S-1/A 2021-02-22 https://www.sec.gov/Archives/edgar/data/1835636/000119312521049392/d12924ds1a.htm
S-1/A S-1/A 2021-02-17 https://www.sec.gov/Archives/edgar/data/1835636/000119312521045442/d12924ds1a.htm
S-1 S-1 2021-02-01 https://www.sec.gov/Archives/edgar/data/1835636/000119312521024747/d12924ds1.htm
DRS 2021-01-14 https://www.sec.gov/Archives/edgar/data/1835636/000095012321000330/filename1.htm